Penn Medicine Abramson Cancer Center


 

Penn Medicine Updates on the OS & ORR in the RELATIVITY-047 Trial: Nivo + Rela vs. Nivo in 1L Metastatic/Unresectable Melanoma

0 views
July 14, 2022
Comments 0
Login to view comments. Click here to Login